BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66:564-574. [PMID: 28422306 DOI: 10.1002/hep.29219] [Cited by in Crossref: 187] [Cited by in F6Publishing: 154] [Article Influence: 46.8] [Reference Citation Analysis]
Number Citing Articles
1 Rodríguez-Perálvarez M, Gómez-Bravo MÁ, Sánchez-Antolín G, De la Rosa G, Bilbao I, Colmenero J; Spanish Society of Liver Transplantation (SETH) Consensus Panel. Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation. Transplantation 2021;105:602-7. [PMID: 32345868 DOI: 10.1097/TP.0000000000003281] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
2 Williams FR, Berzigotti A, Lord JM, Lai JC, Armstrong MJ. Review article: impact of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:988-1000. [PMID: 31502264 DOI: 10.1111/apt.15491] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
3 Murphy SL, Tapper EB, Blackwood J, Richardson JK. Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research. Dig Dis Sci 2019;64:316-23. [PMID: 30327964 DOI: 10.1007/s10620-018-5333-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ney M, Tangri N, Dobbs B, Bajaj J, Rolfson D, Ma M, Ferguson T, Bhardwaj P, Bailey RJ, Abraldes J, Tandon P. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis. Am J Gastroenterol 2018;113:1506-15. [PMID: 30267028 DOI: 10.1038/s41395-018-0243-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
5 Van Jacobs AC. Frailty Assessment in Patients with Liver Cirrhosis. Clin Liver Dis (Hoboken) 2019;14:121-5. [PMID: 31632663 DOI: 10.1002/cld.825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Javaid N, Iqbal AZ, Hameeda M. NUTRITIONAL MANAGEMENT OF LIVER CIRRHOSIS AND ITS COMPLICATIONS IN HOSPITALIZED PATIENTS. Arq Gastroenterol 2021;58:246-52. [PMID: 34287534 DOI: 10.1590/S0004-2803.202100000-43] [Reference Citation Analysis]
7 Shamseddeen H, Pike F, Ghabril M, Patidar KR, Desai AP, Nephew L, Anderson M, Kubal C, Chalasani N, Orman ES. Karnofsky performance status predicts outcomes in candidates for simultaneous liver-kidney transplant. Clin Transplant 2021;35:e14190. [PMID: 33320383 DOI: 10.1111/ctr.14190] [Reference Citation Analysis]
8 Lai JC, Dodge JL, McCulloch CE, Covinsky KE, Singer JP. Frailty and the Burden of Concurrent and Incident Disability in Patients With Cirrhosis: A Prospective Cohort Study. Hepatol Commun 2020;4:126-33. [PMID: 31909360 DOI: 10.1002/hep4.1444] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
9 El Sherif O, Dhaliwal A, Newsome PN, Armstrong MJ. Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. Expert Rev Gastroenterol Hepatol 2020;14:197-205. [PMID: 32064966 DOI: 10.1080/17474124.2020.1731303] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
10 Cullaro G, Park M, Lai JC. "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With Cirrhosis. Hepatology. 2018;68:1953-1960. [PMID: 29698588 DOI: 10.1002/hep.30058] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
11 Tapper EB, Derstine B, Baki J, Su GL. Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis. Dig Dis Sci. 2019;. [PMID: 31292783 DOI: 10.1007/s10620-019-05713-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Agbim U, Asrani SK. The Path Chosen Matters for Patients With Cirrhosis and the Acute Kidney Injury to Chronic Kidney Disease Continuum. Clin Gastroenterol Hepatol 2019;17:2182-4. [PMID: 31004757 DOI: 10.1016/j.cgh.2019.04.030] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mikolasevic I, Pavic T, Kanizaj TF, Bender DV, Domislovic V, Krznaric Z. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? Can J Gastroenterol Hepatol 2020;2020:8859719. [PMID: 33204675 DOI: 10.1155/2020/8859719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tapper EB, Nikirk S, Parikh ND, Zhao L. Falls are common, morbid, and predictable in patients with cirrhosis. J Hepatol 2021;75:582-8. [PMID: 33887359 DOI: 10.1016/j.jhep.2021.04.012] [Reference Citation Analysis]
15 Lattanzi B, Bruni A, Di Cola S, Molfino A, De Santis A, Muscaritoli M, Merli M. The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study. Nutrients 2021;13:2296. [PMID: 34371806 DOI: 10.3390/nu13072296] [Reference Citation Analysis]
16 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
17 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
18 San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P, Ballester MP, Escudero-García D, Tosca J, Montón C, Ríos MP, Kosenko E, Felipo V, Tabares-Seisdedos R, Selva-Vera G, Montoliu C. Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy. J Clin Med 2020;9:E2154. [PMID: 32650464 DOI: 10.3390/jcm9072154] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ito T, Guorgui J, Markovic D, Coy H, Younan SM, DiNorcia J 3rd, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Sarcopenia in high acuity liver transplantation: Does it predict outcomes? Clin Transplant 2021;:e14503. [PMID: 34634157 DOI: 10.1111/ctr.14503] [Reference Citation Analysis]
20 Laube R, Wang H, Park L, Heyman JK, Vidot H, Majumdar A, Strasser SI, McCaughan GW, Liu K. Frailty in advanced liver disease. Liver Int 2018;38:2117-28. [PMID: 29935102 DOI: 10.1111/liv.13917] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 12.3] [Reference Citation Analysis]
21 Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and Frailty in Liver Cirrhosis. Life (Basel) 2021;11:399. [PMID: 33925660 DOI: 10.3390/life11050399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Chiu E, Marr K, Taylor L, Lam L, Stapleton M, Tandon P, Raman M. Malnutrition Impacts Health-Related Quality of Life in Cirrhosis: A Cross-Sectional Study. Nutr Clin Pract 2020;35:119-25. [PMID: 30806489 DOI: 10.1002/ncp.10265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Deng Y, Lin L, Hou L, Fan X, Zhao T, Mao L, Wang X, Wang B, Ma Y, Sun C. A self-reported Frailty Index predicts long-term mortality in hospitalized patients with cirrhosis. Ann Transl Med 2020;8:1217. [PMID: 33178749 DOI: 10.21037/atm-20-943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kapacee ZA, Mcnamara MG, de Liguori Carino N, Lamarca A, Valle JW, Hubner RA. Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare? European Journal of Surgical Oncology 2021;47:583-90. [DOI: 10.1016/j.ejso.2020.03.210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Johnston HE, de Crom T, Hargrave C, Adhyaru P, Woodward AJ, Pang S, Ali A, Coombes JS, Keating SE, McLean K, Mayr HL, Macdonald GA, Hickman IJ. The inter- and intrarater reliability and feasibility of dietetic assessment of sarcopenia and frailty in potential liver transplant recipients: A mixed-methods study. Clin Transplant 2021;35:e14185. [PMID: 33306855 DOI: 10.1111/ctr.14185] [Reference Citation Analysis]
26 Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
27 Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature 2019;571:183-92. [PMID: 31292558 DOI: 10.1038/s41586-019-1365-2] [Cited by in Crossref: 218] [Cited by in F6Publishing: 184] [Article Influence: 109.0] [Reference Citation Analysis]
28 Essam Behiry M, Mogawer S, Yamany A, Rakha M, Awad R, Emad N, Abdelfatah Y. Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis. Int J Hepatol 2019;2019:8092865. [PMID: 31186966 DOI: 10.1155/2019/8092865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
29 Rich NE, Phen S, Desai N, Mittal S, Yopp AC, Yang JD, Marrero JA, Iyengar P, Infante RE, Singal AG. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01036-3. [PMID: 34555519 DOI: 10.1016/j.cgh.2021.09.022] [Reference Citation Analysis]
30 Sidhu SS, Saggar K, Goyal O, Varshney T, Kishore H, Bansal N, Sidhu SS. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease. Eur J Gastroenterol Hepatol 2021;33:555-64. [PMID: 32433422 DOI: 10.1097/MEG.0000000000001761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Moore C, Stein AC. Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis. Clin Liver Dis (Hoboken). 2018;12:113-116. [PMID: 30988924 DOI: 10.1002/cld.758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
32 Lai JC, Covinsky KE, McCulloch CE, Feng S. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis. Am J Gastroenterol 2018;113:235-42. [PMID: 29231189 DOI: 10.1038/ajg.2017.443] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 14.8] [Reference Citation Analysis]
33 Kok B, McNeely M, Watt M, Tandon P. Exercise Only Works If You Do It! The Holy Grail of Adherence. Am J Gastroenterol 2021;116:673-4. [PMID: 33982935 DOI: 10.14309/ajg.0000000000001198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
35 Salim TI, Nestlerode LC, Lucatorto EL, Wasserman TL, Din HA, Landsittel DP, Tevar AD, Johnson JT, Duarte-rojo A, Dunn MA. Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications. Am J Gastroenterol 2020;115:859-66. [DOI: 10.14309/ajg.0000000000000609] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
36 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Reference Citation Analysis]
37 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Reference Citation Analysis]
38 Mouzaki M, Bronsky J, Gupte G, Hojsak I, Jahnel J, Pai N, Quiros-tejeira RE, Wieman R, Sundaram S. Nutrition Support of Children With Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Journal of Pediatric Gastroenterology & Nutrition 2019;69:498-511. [DOI: 10.1097/mpg.0000000000002443] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 8.5] [Reference Citation Analysis]
39 Tandon P, Walling A, Patton H, Taddei T. AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review. Clinical Gastroenterology and Hepatology 2021;19:646-656.e3. [DOI: 10.1016/j.cgh.2020.11.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
40 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
41 Asrani SK, Jennings LW, Kim W, Kamath PS, Levitsky J, Nadim MK, Testa G, Leise MD, Trotter JF, Klintmalm G. MELD‐GRAIL‐Na: Glomerular Filtration Rate and Mortality on Liver‐Transplant Waiting List. Hepatology 2020;71:1766-74. [DOI: 10.1002/hep.30932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
42 Hui Y, Wang X, Yu Z, Feng H, Li C, Mao L, Fan X, Lin L, Cui B, Chen X, Sun L, Wang B, Sun C. Relationship Between Sleep-Wake Disturbance and Risk of Malnutrition in Hospitalized Patients With Cirrhosis. Front Nutr 2021;8:719176. [PMID: 34532336 DOI: 10.3389/fnut.2021.719176] [Reference Citation Analysis]
43 High KP, Zieman S, Gurwitz J, Hill C, Lai J, Robinson T, Schonberg M, Whitson H. Use of Functional Assessment to Define Therapeutic Goals and Treatment. J Am Geriatr Soc 2019;67:1782-90. [PMID: 31081938 DOI: 10.1111/jgs.15975] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
44 Bhanji RA, Watt KD. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation. Liver Transpl 2021;27:1041-53. [PMID: 33713382 DOI: 10.1002/lt.26052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;:1-10. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Reference Citation Analysis]
46 Tandon P, Ismond KP, Riess K, Duarte-rojo A, Al-judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, Mcneely M. Exercise in cirrhosis: Translating evidence and experience to practice. Journal of Hepatology 2018;69:1164-77. [DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 21.7] [Reference Citation Analysis]
47 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
48 Ayorinde T, Panayotova G, Sharma A, Lunsford KE. Clinical and biomarker assessment of frailty in liver transplantation. Curr Opin Organ Transplant 2021. [PMID: 34343156 DOI: 10.1097/MOT.0000000000000911] [Reference Citation Analysis]
49 Artzner T, Michard B, Besch C, Levesque E, Faitot F. Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals. World J Gastroenterol 2018; 24(46): 5203-5214 [PMID: 30581269 DOI: 10.3748/wjg.v24.i46.5203] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
50 Chen HW, Dunn MA. Arresting frailty and sarcopenia in cirrhosis: Future prospects. Clin Liver Dis (Hoboken) 2018;11:52-7. [PMID: 30992788 DOI: 10.1002/cld.691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
51 Bhanji RA, Takahashi N, Moynagh MR, Narayanan P, Angirekula M, Mara KC, Dierkhising RA, Watt KD. The evolution and impact of sarcopenia pre- and post-liver transplantation. Aliment Pharmacol Ther 2019;49:807-13. [PMID: 30714184 DOI: 10.1111/apt.15161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
52 By the Contributors to the C4 Article (Appendix 1). Current opinions in organ allocation. Am J Transplant 2018;18:2625-34. [PMID: 30303603 DOI: 10.1111/ajt.15094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Mazzarelli C, Prentice WM, Heneghan MA, Belli LS, Agarwal K, Cannon MD. Palliative care in end-stage liver disease: Time to do better? Liver Transpl 2018;24:961-8. [PMID: 29729119 DOI: 10.1002/lt.25193] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
54 Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H. Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res 2018;48:893-904. [PMID: 29734510 DOI: 10.1111/hepr.13192] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
55 Zhou K, Dodge JL, Xu E, Emamaullee J, Kahn JA. Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation. Clin Transplant 2021;:e14527. [PMID: 34731515 DOI: 10.1111/ctr.14527] [Reference Citation Analysis]
56 Montgomery JR, Englesbe MJ. Changes in Frailty Status: Some Better, Some Worse. Transplantation 2019;103:1540-1. [PMID: 30753176 DOI: 10.1097/TP.0000000000002564] [Reference Citation Analysis]
57 Mahgoub S, Armstrong MJ, Ferguson JW. Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascites. Aliment Pharmacol Ther 2020;52:885-6. [PMID: 32852822 DOI: 10.1111/apt.15982] [Reference Citation Analysis]
58 Xu CQ, Yao F, Mohamad Y, Wong R, Kent D, Seetharaman S, Srisengfa Y, Lai JC. Evaluating the Associations Between the Liver Frailty Index and Karnofsky Performance Status With Waitlist Mortality. Transplant Direct 2021;7:e651. [PMID: 33437866 DOI: 10.1097/TXD.0000000000001097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Waterman BL, Ramsey SU, Whitsett MP, Patel AA, Radcliff JA, Kotler DL, Winters AC, Woodrell CD, Ufere NN, Serper M, Walling AM, Jones CA, Kelly SG. Top Ten Tips Palliative Care Clinicians Should Know About End-Stage Liver Disease. J Palliat Med 2021;24:924-31. [PMID: 33733875 DOI: 10.1089/jpm.2021.0097] [Reference Citation Analysis]
60 Kremer WM, Nagel M, Reuter M, Hilscher M, Michel M, Kaps L, Labenz J, Galle PR, Sprinzl MF, Wörns MA, Labenz C. Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis. Clin Transl Gastroenterol 2020;11:e00211. [PMID: 32764204 DOI: 10.14309/ctg.0000000000000211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
61 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases. J Clin Med 2020;9:E1570. [PMID: 32455875 DOI: 10.3390/jcm9051570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
62 Ruiz-Margáin A, Román-Calleja BM, Moreno-Guillén P, González-Regueiro JA, Kúsulas-Delint D, Campos-Murguía A, Flores-García NC, Macías-Rodríguez RU. Nutritional therapy for hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(10): 1440-1452 [PMID: 34721776 DOI: 10.4251/wjgo.v13.i10.1440] [Reference Citation Analysis]
63 Alexopoulos T, Vasilieva L, Kontogianni MD, Mani I, Alexopoulou A. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately. Aliment Pharmacol Ther 2021;54:981-2. [PMID: 34506659 DOI: 10.1111/apt.16564] [Reference Citation Analysis]
64 Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E, Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, Lai JC. Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant 2019;19:984-94. [PMID: 30506632 DOI: 10.1111/ajt.15198] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 23.7] [Reference Citation Analysis]
65 Skladany L, Molcan P, Vnencakova J, Vrbova P, Kukla M, Laffers L, Koller T. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis. Can J Gastroenterol Hepatol 2021;2021:5576531. [PMID: 34095016 DOI: 10.1155/2021/5576531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Román E, Parramón M, Flavià M, Gely C, Poca M, Gallego A, Santesmases R, Hernández E, Nieto JC, Urgell E, Alvarado‐tapias E, Vidal S, Ferrero‐gregori A, Vargas V, Guarner C, Soriano G. Frailty in outpatients with cirrhosis: A prospective observational study. Liver Int 2021;41:357-68. [DOI: 10.1111/liv.14694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Loftus TJ, Brown MP, Slish JH, Rosenthal MD. Serum Levels of Prealbumin and Albumin for Preoperative Risk Stratification. Nutrition in Clinical Practice 2019;34:340-8. [DOI: 10.1002/ncp.10271] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
68 Thuluvath PJ, Hanish S, Savva Y. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis. Transplantation. 2019;103:113-121. [PMID: 29985186 DOI: 10.1097/tp.0000000000002355] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
69 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Abo M, Saruta M, Tsubota A. Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. J Clin Med 2020;9:E2381. [PMID: 32722566 DOI: 10.3390/jcm9082381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
70 Lai JC, Segev DL, McCulloch CE, Covinsky KE, Dodge JL, Feng S. Physical frailty after liver transplantation. Am J Transplant 2018;18:1986-94. [PMID: 29380529 DOI: 10.1111/ajt.14675] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 18.7] [Reference Citation Analysis]
71 Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2020;18:2650-2666. [PMID: 31401364 DOI: 10.1016/j.cgh.2019.07.060] [Cited by in Crossref: 102] [Cited by in F6Publishing: 110] [Article Influence: 51.0] [Reference Citation Analysis]
72 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points. In Vivo 2020;34:2549-59. [PMID: 32871784 DOI: 10.21873/invivo.12072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Reference Citation Analysis]
74 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
75 Salim T, Stark SA, Duarte-rojo A. Food as Therapy for Frailty. Curr Hepatology Rep 2020;19:23-9. [DOI: 10.1007/s11901-020-00509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
77 Rachakonda V, Argemi J, Borhani AA, Bataller R, Tevar A, Behari J. Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00013. [PMID: 30908309 DOI: 10.14309/ctg.0000000000000013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
78 Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, Szabo G, Tandon P, Olson J, Karvellas C, Gustot T, Lai JC, Wong F. Acute-on-Chronic Liver Failure: Getting Ready for Prime Time? Hepatology 2018;68:1621-32. [PMID: 29689120 DOI: 10.1002/hep.30056] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 18.7] [Reference Citation Analysis]
79 Yoon U, Topper J, Goldhammer J. Preoperative Evaluation and Anesthetic Management of Patients With Liver Cirrhosis Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2020:S1053-0770(20)30816-8. [PMID: 32891522 DOI: 10.1053/j.jvca.2020.08.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Murphy SL, Richardson JK, Blackwood J, Martinez B, Tapper EB. Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis. Dig Dis Sci 2020;65:3734-43. [PMID: 31982996 DOI: 10.1007/s10620-020-06099-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
81 Kuo SZ, Ahmad M, Dunn MA, Montano-Loza AJ, Carey EJ, Lin S, Moghe A, Chen HW, Ebadi M, Lai JC. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation 2019;103:2312-7. [PMID: 30985575 DOI: 10.1097/TP.0000000000002741] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
82 Cardona M, Lewis ET, Kristensen MR, Skjøt-Arkil H, Ekmann AA, Nygaard HH, Jensen JJ, Jensen RO, Pedersen JL, Turner RM, Garden F, Alkhouri H, Asha S, Mackenzie J, Perkins M, Suri S, Holdgate A, Winoto L, Chang DCW, Gallego-Luxan B, McCarthy S, Petersen JA, Jensen BN, Backer Mogensen C, Hillman K, Brabrand M. Predictive validity of the CriSTAL tool for short-term mortality in older people presenting at Emergency Departments: a prospective study. Eur Geriatr Med 2018;9:891-901. [PMID: 30574216 DOI: 10.1007/s41999-018-0123-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
83 Wong RJ, Mohamad Y, Srisengfa YT, Kent DS, Seetharaman S, Shah RJ, Lai JC. Psychological contributors to the frail phenotype: The association between resilience and frailty in patients with cirrhosis. Am J Transplant 2021;21:241-6. [PMID: 32524691 DOI: 10.1111/ajt.16131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
84 Puchades Renau L, Herreras López J, Cebrià I Iranzo MÀ, Cezón Serrano N, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Reference Citation Analysis]
85 Knoop V, Costenoble A, Vella Azzopardi R, Vermeiren S, Debain A, Jansen B, Scafoglieri A, Bautmans I, Bautmans I, Verté D, Beyer I, Petrovic M, De Donder L, Kardol T, Rossi G, Clarys P, Scafoglieri A, Cattrysse E, de Hert P, Jansen B. The operationalization of fatigue in frailty scales: a systematic review. Ageing Research Reviews 2019;53:100911. [DOI: 10.1016/j.arr.2019.100911] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
86 Wiering L, Öllinger R, Kruppa J, Schoeneberg U, Dziodzio T, Jara M, Biebl M, Dargie R, Raschzok N, Schöning W, Eurich D, Schmelzle M, Sauer IM, Pratschke J, Ritschl PV. Hospitalization Before Liver Transplantation Predicts Posttransplant Patient Survival: A Propensity Score-Matched Analysis. Liver Transpl 2020;26:628-39. [PMID: 32159923 DOI: 10.1002/lt.25748] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin Transl Gastroenterol 2019;10:e00025. [PMID: 30939488 DOI: 10.14309/ctg.0000000000000025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 28.0] [Reference Citation Analysis]
88 Choudhary NS, Sonavane A, Saraf N, Saigal S, Rastogi A, Bhangui P, Thiagrajan S, Yadav SK, Saha S, Soin AS. Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation. J Clin Exp Hepatol 2020;10:37-42. [PMID: 32025165 DOI: 10.1016/j.jceh.2019.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Rubin JB, Sinclair M, Rahimi RS, Tapper EB, Lai JC. Women on the liver transplantation waitlist are at increased risk of hospitalization compared to men. World J Gastroenterol 2019; 25(8): 980-988 [PMID: 30833803 DOI: 10.3748/wjg.v25.i8.980] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
90 Dunn MA, Kappus MR, Bloomer PM, Duarte-Rojo A, Josbeno DA, Jakicic JM. Wearables, Physical Activity, and Exercise Testing in Liver Disease. Semin Liver Dis 2021;41:128-35. [PMID: 33788206 DOI: 10.1055/s-0040-1716564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Wang CW, Lebsack A, Chau S, Lai JC. The Range and Reproducibility of the Liver Frailty Index. Liver Transpl 2019;25:841-7. [PMID: 30884128 DOI: 10.1002/lt.25449] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
92 Chen HW, Ferrando AA, Dunn MA, Kim WR, Duarte‐rojo A. Cadence From Physical Activity Trackers for Monitoring of Home‐Based Exercise Intensity in Advanced Liver Disease. Liver Transpl 2020;26:718-21. [DOI: 10.1002/lt.25745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
93 Becchetti C, Bosch J. Muscle abnormalities in cirrhosis: Calling for more strength in evaluation and prevention. Dig Liver Dis 2019;51:1500-1. [PMID: 31542219 DOI: 10.1016/j.dld.2019.08.015] [Reference Citation Analysis]
94 Xu CQ, Mohamad Y, Kappus MR, Boyarsky B, Ganger DR, Volk ML, Rahimi RS, Duarte-Rojo A, McAdams-DeMarco M, Segev DL, Ladner DP, Verna EC, Grab J, Tincopa M, Dunn MA, Lai JC. The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver Int 2021. [PMID: 34219362 DOI: 10.1111/liv.15006] [Reference Citation Analysis]
95 Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical Function, Physical Activity, and Quality of Life After Liver Transplantation. Liver Transpl 2020;26:702-8. [PMID: 32128971 DOI: 10.1002/lt.25742] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 19.0] [Reference Citation Analysis]
96 Bittermann T, Dwinnells K, Chadha S, Wolf MS, Olthoff KM, Serper M. Low Health Literacy Is Associated With Frailty and Reduced Likelihood of Liver Transplant Listing: A Prospective Cohort Study. Liver Transpl 2020;26:1409-21. [PMID: 32567232 DOI: 10.1002/lt.25830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
97 Hirota K, Kawaguchi T, Koya S, Nagamatsu A, Tomita M, Hashida R, Nakano D, Niizeki T, Matsuse H, Shiba N, Torimura T. Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma. Hepatol Res 2020;50:330-41. [PMID: 31721387 DOI: 10.1111/hepr.13453] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
98 Burton JR Jr, Terrault NA, Goldberg DS, Bloom RD, Gilroy R, Heimbach JK, Brown RS Jr, Everson GT, Rubin E, Wiesner R, Pomfret EA. Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation. Transplantation 2020;104:476-81. [PMID: 31634329 DOI: 10.1097/TP.0000000000003014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
99 Ivanics T, Abreu P, De Martin E, Sapisochin G. Changing Trends in Liver Transplantation: Challenges and Solutions. Transplantation 2021;105:743-56. [PMID: 32910093 DOI: 10.1097/TP.0000000000003454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
100 Kukla M, Skladany L, Menżyk T, Derra A, Stygar D, Skonieczna M, Hudy D, Nabrdalik K, Gumprecht J, Marlicz W, Koulaouzidis A, Koller T. Irisin in Liver Cirrhosis. J Clin Med 2020;9:E3158. [PMID: 33003490 DOI: 10.3390/jcm9103158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
101 Raveh Y, Livingstone J, Mahan J, Tekin A, Selvaggi G, Bowdon‐romero M, Nicolau‐raducu R. Comprehensive Frailty Severity Index for End‐Stage Liver Disease Predicts Early Outcomes After Liver Transplantation. Journal of Parenteral and Enteral Nutrition 2020;44:1079-88. [DOI: 10.1002/jpen.1729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Román E, Nieto JC, Gely C, Vidal S, Pozuelo M, Poca M, Juárez C, Guarner C, Manichanh C, Soriano G. Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial. Hepatol Commun 2019;3:632-45. [PMID: 31061952 DOI: 10.1002/hep4.1325] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
103 Sinha R. Editorial: moving towards a robust definition of sarcopenia in cirrhosis. Aliment Pharmacol Ther 2019;49:340-1. [PMID: 30663102 DOI: 10.1111/apt.15070] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Fozouni L, Wang CW, Lai JC. Sex Differences in the Association Between Frailty and Sarcopenia in Patients With Cirrhosis. Clin Transl Gastroenterol 2019;10:e00102. [PMID: 31789932 DOI: 10.14309/ctg.0000000000000102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
105 Pazniokas J, Gandhi C, Theriault B, Schmidt M, Cole C, Al-Mufti F, Santarelli J, Bowers CA. The immense heterogeneity of frailty in neurosurgery: a systematic literature review. Neurosurg Rev 2021;44:189-201. [PMID: 31953785 DOI: 10.1007/s10143-020-01241-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
106 Maurice J, Pinzani M. The stratification of cirrhosis. Hepatol Res 2020;50:535-41. [PMID: 32072721 DOI: 10.1111/hepr.13493] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
107 Zucchelli A, Marengoni A, Rizzuto D, Calderón-Larrañaga A, Zucchelli M, Bernabei R, Onder G, Fratiglioni L, Vetrano DL. Using a genetic algorithm to derive a highly predictive and context-specific frailty index. Aging (Albany NY) 2020;12:7561-75. [PMID: 32343260 DOI: 10.18632/aging.103118] [Reference Citation Analysis]
108 Li M, Zhao Y, Liu X, Dang Z, Wang X, Jiang Y, Yang Z. Association and interaction between model for end-stage liver disease score and minimally invasive treatment with regard to mortality of patients with hepatitis B virus-associated hepatocellular carcinoma and portal vein tumor thrombi. Oncol Lett 2019;17:119-26. [PMID: 30655746 DOI: 10.3892/ol.2018.9590] [Reference Citation Analysis]
109 DeMaria S Jr, Khromava M, Schiano TD, Lin HM, Kim S. Standardized measures of frailty predict hospital length of stay following orthotopic liver transplantation for hepatocellular carcinoma. Clin Transplant 2019;33:e13746. [PMID: 31664734 DOI: 10.1111/ctr.13746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Lin YJ, Chen RJ, Tang JH, Yu CS, Wu JL, Chen LC, Chang SS. Machine-Learning Monitoring System for Predicting Mortality Among Patients With Noncancer End-Stage Liver Disease: Retrospective Study. JMIR Med Inform 2020;8:e24305. [PMID: 33124991 DOI: 10.2196/24305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Dunn MA. The cost of sarcopenia. Transpl Int 2018;31:155-6. [DOI: 10.1111/tri.13069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Lai JC, Rahimi RS, Verna EC, Kappus MR, Dunn MA, McAdams-DeMarco M, Haugen CE, Volk ML, Duarte-Rojo A, Ganger DR, O'Leary JG, Dodge JL, Ladner D, Segev DL. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology 2019;156:1675-82. [PMID: 30668935 DOI: 10.1053/j.gastro.2019.01.028] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 33.5] [Reference Citation Analysis]
114 Tapper EB, Konerman M, Murphy S, Sonnenday CJ. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant 2018;18:2566-70. [PMID: 30019835 DOI: 10.1111/ajt.15020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 9.7] [Reference Citation Analysis]
115 Burra P, Samuel D, Sundaram V, Duvoux C, Petrowsky H, Terrault N, Jalan R. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation. J Hepatol 2021;75 Suppl 1:S178-90. [PMID: 34039488 DOI: 10.1016/j.jhep.2021.01.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
116 Oloruntoba OO, Moylan CA. "Too Female" for Liver Transplantation. Hepatology 2018;68:2424-5. [PMID: 29679376 DOI: 10.1002/hep.30053] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
117 Deng LX, Kent DS, O'Riordan DL, Pantilat SZ, Lai JC, Bischoff KE. Symptom Burden Is Associated with Increased Emergency Department Utilization among Patients with Cirrhosis. J Palliat Med 2021. [PMID: 34348042 DOI: 10.1089/jpm.2021.0219] [Reference Citation Analysis]
118 Louissaint J, Murphy SL, Sonnenday CJ, Lok AS, Tapper EB. Applying Administrative Data-Based Coding Algorithms for Frailty in Patients With Cirrhosis. Liver Transpl 2021. [PMID: 33871175 DOI: 10.1002/lt.26078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Lin FP, Visina JM, Bloomer PM, Dunn MA, Josbeno DA, Zhang X, Clemente-Sanchez A, Tevar AD, Hughes CB, Jakicic JM, Duarte-Rojo A. Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. Am J Gastroenterol 2021. [PMID: 34313620 DOI: 10.14309/ajg.0000000000001376] [Reference Citation Analysis]
120 Lai JC, Dodge JL, Kappus MR, Wong R, Mohamad Y, Segev DL, McAdams-DeMarco M. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol 2021;116:717-22. [PMID: 33982941 DOI: 10.14309/ajg.0000000000001113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
121 Spiers GF, Kunonga TP, Hall A, Beyer F, Boulton E, Parker S, Bower P, Craig D, Todd C, Hanratty B. Measuring frailty in younger populations: a rapid review of evidence. BMJ Open 2021;11:e047051. [PMID: 33753447 DOI: 10.1136/bmjopen-2020-047051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Kok B, Tandon P. Frailty in Patients With Cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215-225. [PMID: 29589278 DOI: 10.1007/s11938-018-0179-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
123 Cullaro G, Verna EC, Duarte-Rojo A, Kappus MR, Ganger DR, Rahimi RS, Boyarsky B, Segev DL, McAdams-DeMarco M, Ladner DP, Volk ML, Hsu CY, Lai JC. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34676697 DOI: 10.1002/hep4.1840] [Reference Citation Analysis]
124 Kahn J, Wagner D, Homfeld N, Müller H, Kniepeiss D, Schemmer P. Both sarcopenia and frailty determine suitability of patients for liver transplantation-A systematic review and meta-analysis of the literature. Clin Transplant 2018;32:e13226. [DOI: 10.1111/ctr.13226] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 9.7] [Reference Citation Analysis]
125 Ravikiran SK, Bhat M. Editorial: effect of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:1241-2. [PMID: 31709608 DOI: 10.1111/apt.15534] [Reference Citation Analysis]
126 Kuo SZ, Lizaola B, Hayssen H, Lai JC. Beta-blockers and physical frailty in patients with end-stage liver disease. World J Gastroenterol 2018; 24(33): 3770-3775 [PMID: 30197482 DOI: 10.3748/wjg.v24.i33.3770] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
127 Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant. 2019;19:1896-1906. [PMID: 30980701 DOI: 10.1111/ajt.15392] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
128 Kriss M, Biggins SW. Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process. Curr Opin Organ Transplant 2021;26:52-61. [PMID: 33278150 DOI: 10.1097/MOT.0000000000000829] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 24.3] [Reference Citation Analysis]
130 Zahed M, Ranjbar MA, Azad A. Oral Health-Related Quality of Life in Chronic Liver Failure Patients Measured by OHIP-14 and GOHAI. Biomed Res Int 2020;2020:8835824. [PMID: 33426077 DOI: 10.1155/2020/8835824] [Reference Citation Analysis]
131 Kardashian A, Ge J, McCulloch CE, Kappus MR, Dunn MA, Duarte-Rojo A, Volk ML, Rahimi RS, Verna EC, Ganger DR, Ladner D, Dodge JL, Boyarsky B, McAdams-DeMarco M, Segev DL, Lai JC. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology 2021;73:1132-9. [PMID: 32491208 DOI: 10.1002/hep.31406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
132 Tapper EB. Frailty and Outcomes After Liver Transplantation. Curr Transplant Rep 2019;6:1-6. [PMID: 31602355 DOI: 10.1007/s40472-019-0222-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
133 Lai JC, Dodge JL, Kappus MR, Dunn MA, Volk ML, Duarte-Rojo A, Ganger DR, Rahimi RS, McCulloch CE, Haugen CE, McAdams-DeMarco M, Ladner DP, Segev DL, Verna EC; Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Changes in frailty are associated with waitlist mortality in patients with cirrhosis. J Hepatol 2020;73:575-81. [PMID: 32240717 DOI: 10.1016/j.jhep.2020.03.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 31.0] [Reference Citation Analysis]
134 Serper M, Tao SY, Kent DS, Garren P, Burdzy AE, Lai JC, Gougol A, Bloomer PM, Reddy KR, Dunn MA, Duarte-Rojo A. Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis. Liver Transpl 2021. [PMID: 34018303 DOI: 10.1002/lt.26100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease. Nutrients 2020;12:E3810. [PMID: 33322706 DOI: 10.3390/nu12123810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
136 Perito ER, Bucuvalas J, Lai JC. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates. Am J Transplant 2019;19:1388-96. [PMID: 30506640 DOI: 10.1111/ajt.15203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
137 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Reference Citation Analysis]
138 Berry K, Duarte-Rojo A, Grab JD, Dunn MA, Boyarsky BJ, Verna EC, Kappus MR, Volk ML, McAdams-DeMarco M, Segev DL, Ganger DR, Ladner DP, Shui A, Tincopa MA, Rahimi RS, Lai JC; from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Cognitive Impairment and Physical Frailty in Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34558844 DOI: 10.1002/hep4.1796] [Reference Citation Analysis]
139 Rana A, Witte ED, Halazun KJ, Sood GK, Mindikoglu AL, Sussman NL, Vierling JM, Kueht ML, Galvan NTN, Cotton RT, O'mahony CA, Goss JA. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant 2017;31:e13141. [DOI: 10.1111/ctr.13141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
140 Mahmud N, Goldberg DS. Declining predictive performance of the MELD: Cause for concern or reflection of changes in clinical practice? Am J Transplant 2019;19:3221-2. [PMID: 31553133 DOI: 10.1111/ajt.15606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Dasarathy S. Myostatin and beyond in cirrhosis: All roads lead to sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8:864-869. [PMID: 29168629 DOI: 10.1002/jcsm.12262] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
142 Haugen CE, McAdams-DeMarco M, Holscher CM, Ying H, Gurakar AO, Garonzik-Wang J, Cameron AM, Segev DL, Lai JC. Multicenter Study of Age, Frailty, and Waitlist Mortality Among Liver Transplant Candidates. Ann Surg 2020;271:1132-6. [PMID: 30672803 DOI: 10.1097/SLA.0000000000003207] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 27.0] [Reference Citation Analysis]
143 Merli M. Nutrition in cirrhosis: Dos and Don’ts. Journal of Hepatology 2020;73:1563-5. [DOI: 10.1016/j.jhep.2020.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
144 Tapper EB, Baki J, Parikh ND, Lok AS. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis. Hepatology 2019;69:1676-85. [PMID: 30382584 DOI: 10.1002/hep.30336] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
145 Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol 2018;15:753-64. [DOI: 10.1038/s41575-018-0045-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
146 Panchangam C, White DA, Goudar S, Birnbaum B, Malloy-Walton L, Gross-Toalson J, Reid KJ, Shirali G, Parthiban A. Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease. Pediatr Cardiol 2020;41:1031-41. [PMID: 32377892 DOI: 10.1007/s00246-020-02354-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
147 Duarte-Rojo A, Bloomer PM, Rogers RJ, Hassan MA, Dunn MA, Tevar AD, Vivis SL, Bataller R, Hughes CB, Ferrando AA, Jakicic JM, Kim WR. Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates. Liver Transpl. 2021;27:502-512. [PMID: 33232547 DOI: 10.1002/lt.25950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
148 Hanai T, Shiraki M, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis. Hepatol Res 2019;49:1414-26. [PMID: 31408558 DOI: 10.1111/hepr.13420] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
149 Abdelbasset WK, Nambi G, Elsayed SH, Moawd SA, Ibrahim AA, Verma A, Tantawy SA, Kamel DM, Saleh AK, Aldhafian OR, Nwihadh NB. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. Dis Markers 2021;2021:8866093. [PMID: 33628339 DOI: 10.1155/2021/8866093] [Reference Citation Analysis]
150 Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clinics in Liver Disease 2019;23:589-605. [DOI: 10.1016/j.cld.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
151 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Reference Citation Analysis]
152 Varughese RA, Theou O, Li Y, Huang X, Chowdhury N, Famure O, Selzner N, MacIver J, Mathur S, Kim SJ, Rockwood K, Singer LG. Cumulative Deficits Frailty Index Predicts Outcomes for Solid Organ Transplant Candidates. Transplant Direct 2021;7:e677. [PMID: 34113716 DOI: 10.1097/TXD.0000000000001094] [Reference Citation Analysis]
153 Haugen CE, McAdams-DeMarco M, Verna EC, Rahimi RS, Kappus MR, Dunn MA, Volk ML, Gurakar A, Duarte-Rojo A, Ganger DR, O'Leary JG, Ladner D, Garonzik-Wang J, Segev DL, Lai JC. Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index. JAMA Surg 2019;154:1103-9. [PMID: 31509169 DOI: 10.1001/jamasurg.2019.2845] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
154 Fozouni L, Mohamad Y, Lebsack A, Freise C, Stock P, Lai JC. Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation. Liver Transpl 2020;26:390-6. [PMID: 31655014 DOI: 10.1002/lt.25669] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
155 Tapper EB, Wexler R, Goldman E, Volk M. Constitutional Challenges to Liver Transplant Policy. Transplantation 2019;103:e378-81. [PMID: 31259856 DOI: 10.1097/TP.0000000000002703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
156 Chakravarthy MV, Neutel J, Confer S, Zhao P, Tatsuta N, Rebello S, Comb WC, Hamill M, Tramontin T, Carroll S, Afeyan R, Sanyal AJ. Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis. Clin Transl Gastroenterol 2020;11:e00222. [PMID: 32955200 DOI: 10.14309/ctg.0000000000000222] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
157 Linecker M, Krones T, Berg T, Niemann CU, Steadman RH, Dutkowski P, Clavien PA, Busuttil RW, Truog RD, Petrowsky H. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits. J Hepatol. 2018;68:798-813. [PMID: 29133246 DOI: 10.1016/j.jhep.2017.11.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
158 Thompson C, Taleban S. Incorporating Frailty in the Treatment Program of Elderly Patients with Gastrointestinal Disease. Curr Treat Options Gastro 2020;18:635-56. [DOI: 10.1007/s11938-020-00310-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Deng Y, Lin L, Fan X, Cui B, Hou L, Zhao T, Hou J, Mao L, Wang X, Zhao W, Wang B, Yu Q, Sun C. Incorporation of frailty estimated by gait speed within MELD-Na and the predictive potential for mortality in cirrhosis. Ther Adv Chronic Dis 2020;11:2040622320922023. [PMID: 32489574 DOI: 10.1177/2040622320922023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
160 Tsuchihashi J, Koya S, Hirota K, Koga N, Narao H, Tomita M, Kawaguchi T, Hashida R, Nakano D, Tsutsumi T, Yoshio S, Matsuse H, Sanada T, Notsumata K, Torimura T. Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma. Cancers (Basel) 2021;13:E194. [PMID: 33430438 DOI: 10.3390/cancers13020194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24-36. [PMID: 30345878 DOI: 10.1177/0269216318807051] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
162 Federico A, Caprio GG, Dalise AM, Barbieri M, Dallio M, Loguercio C, Paolisso G, Rizzo MR. Cirrhosis and frailty assessment in elderly patients: A paradoxical result. Medicine (Baltimore) 2020;99:e18501. [PMID: 31914020 DOI: 10.1097/MD.0000000000018501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
163 Gilbo N, Jochmans I, Sainz-Barriga M, Nevens F, van der Merwe S, Laleman W, Verslype C, Cassiman D, Verbeke L, van Malenstein H, Roskams T, Pirenne J, Monbaliu D. Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected. Transplant Direct 2019;5:e342. [PMID: 30993187 DOI: 10.1097/TXD.0000000000000883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]